PAMU
NKTR icon

Pictet Asset Management (UK)’s Nektar Therapeutics NKTR Stock Holding History

Pictet Asset Management (UK)’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$199K Sell
773
-207
-21% -$57.3K ﹤0.01% 1648
2021
Q1 		$294K Sell
980
-3,566
-78% -$1.11M ﹤0.01% 1452
2020
Q4 		$1.16M Hold
4,546
– – ﹤0.01% 1005
2020
Q3 		$1.13M Sell
4,546
-2,936
-39% -$923K ﹤0.01% 956
2020
Q2 		$2.6M Sell
7,482
-3,369
-31% -$1.05M ﹤0.01% 824
2020
Q1 		$2.9M Buy
10,851
+4,987
+85% +$1.54M 0.01% 777
2019
Q4 		$1.9M Sell
5,864
-9,277
-61% -$2.69M ﹤0.01% 935
2019
Q3 		$4.14M Buy
15,141
+73
+0.5% +$26.8K 0.01% 742
2019
Q2 		$8.04M Buy
15,068
+9,441
+168% +$4.73M 0.02% 568
2019
Q1 		$2.84M Buy
5,627
+594
+12% +$352K 0.01% 812
2018
Q4 		$2.48K Sell
5,033
-15,264
-75% -$9.21M 0.01% 809
2018
Q3 		$18.6M Sell
20,297
-12,774
-39% -$10.9M 0.04% 431
2018
Q2 		$24.2M Buy
33,071
+478
+1% +$551K 0.06% 357
2018
Q1 		$52M Buy
+32,593
New +$42M 0.13% 220
2017
Q4 		– Sell
-4,060
Closed -$1.46M – 904
2017
Q3 		$1.46M Sell
4,060
-2,653
-40% -$830K ﹤0.01% 809
2017
Q2 		$2M Buy
6,713
+353
+6% +$102K 0.01% 790
2017
Q1 		$2.24M Sell
6,360
-3,500
-35% -$787K 0.01% 763
2016
Q4 		$1.81M Buy
+9,860
New +$2M 0.01% 763

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Pictet Asset Management (UK)'s NKTR Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its Nektar Therapeutics (NKTR) stake by 21% in Q2 2021, selling an estimated $57.3K and leaving 773 shares worth $199K. The position accounts for ﹤0.01% of the portfolio, ranked #1648.

Pictet Asset Management (UK) first reported a position in NKTR in Q4 2016 and has held it in 18 quarters since. The position peaked at $52M in Q1 2018. 239 funds tracked by Wall St. Rank hold NKTR as of Q2 2021.

  • Pictet Asset Management (UK) held 773 shares of Nektar Therapeutics worth $199K as of Q2 2021.
  • Pictet Asset Management (UK) sold 207 Nektar Therapeutics shares in Q2 2021, an estimated $57.3K.
  • Nektar Therapeutics made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #1648 holding.
  • Pictet Asset Management (UK) first reported a position in Nektar Therapeutics in Q4 2016 and has held it in 18 quarters since.
  • Pictet Asset Management (UK)'s Nektar Therapeutics position peaked at $52M in Q1 2018.
  • 239 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.